Dr Reddys Laboratories (RDY) Assets (2009 - 2026)

Dr Reddys Laboratories has reported Assets for 18 years, with the latest figure at $6.1 billion in Q2 2026.

• On a quarterly basis, Assets changed 0.1% year-over-year to $6.1 billion in Q2 2026; TTM through Jun 2026 was $6.1 billion, a 0.1% change from a year earlier, with the FY2026 full-year figure at $6.2 billion, up 6.98% from the prior year.
• Assets was $6.1 billion for Q2 2026 at Dr Reddys Laboratories, down from $6.3 billion in the prior quarter.
• The five-year high for Assets was $6.3 billion in Q1 2026, with the low at $3.6 billion in Q3 2022.
• Average Assets over 5 years is $5.0 billion, with a median of $4.8 billion recorded in 2024.
• The sharpest annual moves came in 2022 and 2024: Assets slipped 2.9% in 2022, then jumped 32.52% in 2024.
• Over 5 years, Assets stood at $3.8 billion in 2022, then advanced by 18.86% to $4.5 billion in 2023, then rose by 27.24% to $5.7 billion in 2024, then climbed by 10.94% to $6.3 billion in 2025, then decreased by 3.86% to $6.1 billion in 2026.
• The last three Assets figures came in at $6.1 billion (Q2 2026), $6.3 billion (Q1 2026), and $6.3 billion (Q4 2025), per Business Quant data.